These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 35150065)

  • 1. Respiratory syncytial virus-associated acute respiratory illness in adult non-immunocompromised patients: Outcomes, determinants of outcomes, and the effect of oral ribavirin treatment.
    Wongsurakiat P; Sunhapanit S; Muangman N
    Influenza Other Respir Viruses; 2022 Jul; 16(4):767-779. PubMed ID: 35150065
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Oral ribavirin therapy for respiratory syncytial virus infections in moderately to severely immunocompromised patients.
    Marcelin JR; Wilson JW; Razonable RR;
    Transpl Infect Dis; 2014 Apr; 16(2):242-50. PubMed ID: 24621016
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Epidemiology and outcomes of hospitalized adults with respiratory syncytial virus: A 6-year retrospective study.
    Schmidt H; Das A; Nam H; Yang A; Ison MG
    Influenza Other Respir Viruses; 2019 Jul; 13(4):331-338. PubMed ID: 30977284
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognosis of hospitalised adult patients with respiratory syncytial virus infection: a multicentre retrospective cohort study.
    Celante H; Oubaya N; Fourati S; Beaune S; Khellaf M; Casalino E; Ricard JD; Vieillard-Baron A; Heming N; Mekontso Dessap A; de Montmollin E; Benghanem S; Epaillard N; Layese R; de Prost N;
    Clin Microbiol Infect; 2023 Jul; 29(7):943.e1-943.e8. PubMed ID: 36914069
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prophylaxis and treatment of respiratory syncytial virus in adult immunocompromised patients.
    Hynicka LM; Ensor CR
    Ann Pharmacother; 2012 Apr; 46(4):558-66. PubMed ID: 22395247
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparative effectiveness of aerosolized versus oral ribavirin for the treatment of respiratory syncytial virus infections: A single-center retrospective cohort study and review of the literature.
    Trang TP; Whalen M; Hilts-Horeczko A; Doernberg SB; Liu C
    Transpl Infect Dis; 2018 Apr; 20(2):e12844. PubMed ID: 29360277
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy of oral ribavirin in lung transplant patients with respiratory syncytial virus lower respiratory tract infection.
    Pelaez A; Lyon GM; Force SD; Ramirez AM; Neujahr DC; Foster M; Naik PM; Gal AA; Mitchell PO; Lawrence EC
    J Heart Lung Transplant; 2009 Jan; 28(1):67-71. PubMed ID: 19134533
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intravenous palivizumab and ribavirin combination for respiratory syncytial virus disease in high-risk pediatric patients.
    Chávez-Bueno S; Mejías A; Merryman RA; Ahmad N; Jafri HS; Ramilo O
    Pediatr Infect Dis J; 2007 Dec; 26(12):1089-93. PubMed ID: 18043443
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Respiratory syncytial virus and parainfluenza virus infections in the immunocompromised host.
    Wendt CH; Hertz MI
    Semin Respir Infect; 1995 Dec; 10(4):224-31. PubMed ID: 8668850
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Respiratory syncytial virus and human metapneumovirus after allogeneic hematopoietic stem cell transplantation: Impact of the immunodeficiency scoring index, viral load, and ribavirin treatment on the outcomes.
    Akhmedov M; Wais V; Sala E; Neagoie A; Nguyen TM; Gantner A; von Harsdorf S; Kuchenbauer F; Schubert A; Michel D; Döhner H; Bunjes D
    Transpl Infect Dis; 2020 Aug; 22(4):e13276. PubMed ID: 32162389
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Current practices for treatment of respiratory syncytial virus and other non-influenza respiratory viruses in high-risk patient populations: a survey of institutions in the Midwestern Respiratory Virus Collaborative.
    Beaird OE; Freifeld A; Ison MG; Lawrence SJ; Theodoropoulos N; Clark NM; Razonable RR; Alangaden G; Miller R; Smith J; Young JA; Hawkinson D; Pursell K; Kaul DR
    Transpl Infect Dis; 2016 Apr; 18(2):210-5. PubMed ID: 26923867
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effectiveness of ribavirin in otherwise well infants with respiratory syncytial virus-associated respiratory failure. Pediatric Critical Study Group.
    Moler FW; Steinhart CM; Ohmit SE; Stidham GL
    J Pediatr; 1996 Mar; 128(3):422-8. PubMed ID: 8774517
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Does ribavirin impact on the hospital course of children with respiratory syncytial virus (RSV) infection? An analysis using the pediatric investigators collaborative network on infections in Canada (PICNIC) RSV database.
    Law BJ; Wang EE; MacDonald N; McDonald J; Dobson S; Boucher F; Langley J; Robinson J; Mitchell I; Stephens D
    Pediatrics; 1997 Mar; 99(3):E7. PubMed ID: 9099772
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ribavirin for Treatment of Subjects with Respiratory Syncytial Virus-Related Infection: A Systematic Review and Meta-Analysis.
    Tejada S; Martinez-Reviejo R; Karakoc HN; Peña-López Y; Manuel O; Rello J
    Adv Ther; 2022 Sep; 39(9):4037-4051. PubMed ID: 35876973
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intravenous ribavirin is a safe and cost-effective treatment for respiratory syncytial virus infection after lung transplantation.
    Glanville AR; Scott AI; Morton JM; Aboyoun CL; Plit ML; Carter IW; Malouf MA
    J Heart Lung Transplant; 2005 Dec; 24(12):2114-9. PubMed ID: 16364859
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Oral versus inhaled ribavirin therapy for respiratory syncytial virus infection after lung transplantation.
    Li L; Avery R; Budev M; Mossad S; Danziger-Isakov L
    J Heart Lung Transplant; 2012 Aug; 31(8):839-44. PubMed ID: 22621746
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Combination therapy with aerosolized ribavirin and intravenous immunoglobulin for respiratory syncytial virus disease in adult bone marrow transplant recipients.
    Whimbey E; Champlin RE; Englund JA; Mirza NQ; Piedra PA; Goodrich JM; Przepiorka D; Luna MA; Morice RC; Neumann JL
    Bone Marrow Transplant; 1995 Sep; 16(3):393-9. PubMed ID: 8535312
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical outcomes in outpatient respiratory syncytial virus infection in immunocompromised children.
    Chu HY; Chin J; Pollard J; Zerr DM; Englund JA
    Influenza Other Respir Viruses; 2016 May; 10(3):205-10. PubMed ID: 26859306
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Successful systemic high-dose ribavirin treatment of respiratory syncytial virus-induced infections occurring pre-engraftment in allogeneic hematopoietic stem cell transplant recipients.
    Gueller S; Duenzinger U; Wolf T; Ajib S; Mousset S; Berger A; Martin H; Serve H; Bug G
    Transpl Infect Dis; 2013 Aug; 15(4):435-40. PubMed ID: 23692664
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Corticosteroid use as adjunct therapy for respiratory syncytial virus infection in adult allogeneic stem cell transplant recipients.
    Damlaj M; Bartoo G; Cartin-Ceba R; Gijima D; Alkhateeb HB; Merten J; Hashmi S; Litzow M; Gastineau D; Hogan W; Patnaik MM
    Transpl Infect Dis; 2016 Apr; 18(2):216-26. PubMed ID: 26909896
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.